arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Cryoport, Inc.

CYRX
$15.12 ▲ +0.44 (+3.00%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
17 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
45
Health
Weak
Moderately Bullish
auto_awesome

Analytical Summary

Cryoport, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). However, watch Operating Margin (%) which shows concerning trends. Overall, the data suggests a moderately positive outlook with manageable risks.

Market Cap $757.1M
Dividend Yield
Revenue Growth 12.4%
Op. Margin -20.9%
ROIC -7.7%
FCF / Share $-0.50
Trailing P/E 10.8x
Price / Book 1.5x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

17-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$176.18M
↑ +12.4%
Net Income Profit after all expenses
$78.30M
↑ +168.2%
Operating Margin Operating profit as % of sales
-20.9%
↑ +73.1% 10th
FCF / Share Free cash flow per share
$-0.50
↑ +26.6%
Long-Term Debt Long-term obligations
$1.29M
↑ +297.9%
trending_up

Bullish Indicators

  • Profit Margin (%)Profit Margin (%) is in the top quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability
39
Returns
81
Financial Health
23
Cash Quality
15

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 17 years · 66 quarters